Programme


Programme

Congress: Programme Day 3
5th October 2019 (Saturday)

  Diagnostic Track / Topic Highlights
  Hot Topics

FOUNDATION COURSES

Foundation Course 11 (FC 11)
Lecture Hall B, 0730hrs – 0830hrs
Course Objectives:

  • To learn the principles and techniques of cryoablation in renal, lung and spinal tumours.
  • To understand abscopal effects in cryoablation.
  • To learn how to set up a cryoablation service.

Teaching Course In Cryoablation

  • Indications, Case Selections And Choice Of Equipments - Peter Goh, Singapore
  • Physics And Abscopal Effects In Cryoablation - Peter Goh, Singapore
  • Cryoablation In RCC: How Do I Do It? - Nancy Shu-Huei Shen, Chinese Taipei
  • Cryoablation Of Lung: How Do I Do It? - Alda Tam, USA
  • Cryoablation Of Spinal Tumour: How Do I Do It? - Hai-Dong Zhu, China

Foundation Course 12 (FC 12)
Lecture Hall C, 0730hrs – 0830hrs
Course Objectives:

  1. To learn the indications and technical approach in benign thyroid ablation and recurrent papillary thyroid carcinoma.
  2. To learn complications and its management in thyroid ablation.

Basics In Thyroid Ablation

  • Pre-Ablation Assessment For Benign Thyroid Nodules: What Do IRs Need To Know And Patient Selection - TBC
  • Benign Thyroid Nodule Ablation: Technical Approach And How Do I Do It? - Chow Wei Too, Singapore
  • Ablation Treatment For Recurrent Papillary Thyroid Carcinoma: Indications And How Do I Do It? - Somrach Thamtorawat, Thailand
  • Management Of Complications In Thyroid Nodules Ablation - Sheng-Nan Lu, Chinese Taipei

Foundation Course 13 (FC 13)
Lecture Hall D, 0730hrs – 0830hrs
Course Objectives:

  1. To learn advanced imaging for liver tumours and cholangiocarcinoma.
  2. To understand post intervention imaging changes in liver tumour imaging.

Hepatobiliary Imaging Beyond Basics

  • Atypical HCC: Imaging Dilemma - Linda Brown, Thailand
  • What IRs Need To Know Pre And Post Interventions In HCC And Liver Metastases - TBC
  • Surveillance For Small HCC With Contrast-Enhanced Ultrasound: How Do I Do It? - Daehyun Hwang, South Korea
  • Staging Of Cholangiocarcinoma Made Easy - Surachate Siripongsakun, Thailand

FOUNDATION COURSES

Foundation Course 14 (FC 14)
Lecture Hall F, 0730hrs – 0830hrs
Course Objectives:

  1. To understand the basic principles, indications and technical considerations in irreversible electropolation.
  2. To learn complications that may arise from irreversible electropolation and its management.

Irreversible Electropolation (IRE)

  • Basic Principles Of IRE - Tian-An Jiang, China
  • Indications & Contraindications Of IRE - Gerard S Goh, Australia
  • Pre-Procedural Preparations - Tze Min Wah, United Kingdom
  • Technical Approach & Pitfalls - Gerard Goh, Australia
  • Results And Complications - Tian-An Jiang, China
  • My Secret Tricks - Tze Min Wah, United Kingdom

Foundation Course 15 (FC 15)
Lecture Hall G, 0730hrs – 0830hrs
Course Objectives:

  1. To learn advanced techniques in vascular access beyond its conventional placement technique.
  2. To understand the techniques of endovascular treatment for pulmonary embolism in IO setting.
  3. To learn the outcome of SVC and IVC stenting in IO setting.
  4. To learn the technical considerations in lymphangiography and thoracic duct embolisation.

Vascular And Lymphatic Concerns In IO

  • Central Venous Ports And Catheters Access: The Misadventures And Unusual Routes - Nur Yazmin Yaacob, Malaysia
  • Endovascular Techniques And Outcomes In The Management Of Pulmonary Embolism In Oncologic Practice - Sanjiv Sharma, India
  • SVC And IVC Stenosis : Will Stenting Work? - TBC
  • Role Of Lymphangiography And Thoracic Duct Embolisation In Oncology - Arun Gupta, India

FOCUS WORKSHOP

Focus Workshop 8 (FW 8)
Lecture Hall B, 0830hrs – 1000hrs


Radioembolisation In Liver Malignancies

  • Current Role, Indications And New Concepts Of SIRT In Liver Malignancies - Ramon Augusto Hilarion S. Santos-Ocampo, Philippines
  • TheraSphere® In HCC - Rheun-Chuan Lee, Chinese Taipei
  • Curative Intent Therapies In HCC - TBC
  • Radioembolisation In Hepatic Malignancies: Complications And Pitfalls - Norshazriman Sulaiman, Malaysia
  • Proton Beam Therapy In HCC - Norshazrina Sulaiman, Japan
  • Combining Radioembolisation With Immune-Oncologics: How Do I Do It? - Matthew Johnson, USA

Focus Workshop 9 (FW 9)
Lecture Hall D, 0830hrs – 1000hrs


Radioiodine Brachytherapy In Oligometastatic Disease And Visceral Organs

  • Indications, Contraindications And Treatment Planning: What To Consider - Fu-Jun Zhang, China
  • Challenges In Radio-Iodine Services In Malaysia - Basri Johan Jeet Abdullah, Malaysia
  • CT-Guided I-125 Seeds Implantation For The Treatment Of Metastatic Epidural Spinal Cord Compression - Xue-Quan Huang, China
  • Application Of I-125 Seed Implantation In The Treatment Of Lung Metastasis Of Liver Cancer - Rui-Bao Liu, China
  • 3D Printed Template And CT-Guided Brachytherapy For Prostate Cancer - Hong-Tao Zhang, China

Focus Workshop 10 (FW 10))
Lecture Hall B, 1100hrs – 1300hrs


Interventions In Biliary And Pancreatic Malignancies

  • Cholangiocarcinogenesis: Role Of Imaging - Surachate Siripongsakun, Thailand
  • Transarterial Interventions In Cholangiocarcinoma: Technical Options And Outcome - Xiao-Dong Wang, China
  • IO Treatment Of Cholangiocarcinoma - TBC
  • Multiple Interventional Techniques In Comprehensive Treatment Of Hilar Cholangiocarcinoma - Yue-Wei Zhang, China
  • Percutaneous Cryoablation Of Advanced Pancreatic Carcinoma: Technique And Strategy - Hai-Peng Yu, China
  • Combination Therapy Of GEM-proton For Pancreatic Cancer - Norshazrina Sulaiman, Japan
  • Drug Eluting Stents For Malignant Biliary Obstruction - Gerard S Goh, Australia
  • Radioiodine Bead Loaded Brachytherapy In Klatskin Tumour: Technical Options And Results - Hai-Dong Zhu, China

FOCUS WORKSHOPS

Focus Workshop 11 (FW 11)
Lecture Hall A, 1400hrs – 1600hrs


Ablations & TACE Beyond Convention

  • Percutaneous Segmental Ablation In Primary Liver Cancer - Jia-Sheng Zheng, China
  • Tumor Associated Specific T-Cell Immune Response In Hepatocellular Carcinoma - Yong-Hong Zhang, China
  • Clinical Study Of Percutaneous Endobiliary Radiofrequency Ablation And Stent Placement In Malignant Biliary Obstruction - Jia-Ping Li, China
  • Treatment Of Locally Advanced Pancreatic Cancer With Irreversible Electroporation: The Preliminary Experience - Xiao-Yi Ding, China
  • IRE Ablation For Pancreatic Cancer - Li-Zhi Niu, China
  • Radiofrequency Ablation For Synchronous Colorectal Cancer Liver Metastasis - Jing-Yao Huang, China
  • Hepatocellular Carcinoma With Portal Vein Branch Tumor Thrombus: Transarterial Chemoembolisation Combined With Iodine-125 Brachytherapy Versus Transarterial Chemoembolisation Combined With Sorafenib - Jing-Jun Huang, China
  • Sodium Bicarbonate Infusion For Optimisation Of cTACE Intra-Tumoral Lactic Acidosis: Principles And Technical Considerations - Xun Hu, China
  • Sodium Bicarbonate Infusion For Optimisation Of cTACE Intra-Tumoral Lactic Acidosis: Clinical Application And Data Update - Ming Chao, China
  • The Clinical Course And Risk Factors Of Post-Ablation Hemobilia For Hepatocellular Carcinoma - Wei Li, China
  • TACE Plus MWA Vs TACE Alone In Patients With Solitary Large Or Multinodular HCC - Lin Zheng, China

Focus Workshop 12 (FW 12)
Lecture Hall B, 1400hrs – 1600hrs


Portal Vein Interventions In IO

  • Portal Vein Embolisation: Principles And Techniques - TBC
  • TIPS In IO: Indications And Outcome - Sundeep Jaywantraj Punamiya, Singapore
  • Transplenic TIPS - Matthew Johnson, USA
  • Management Of AP And AV Shunts In HCC - John Sang Joon Park, South Korea
  • Stenting In Malignant Portal Vein Occlusion: Options And Results - Hua Xiang, China
  • HAIC In Malignant PV Invasion : Feasibility And Outcome - Rui-Bao Liu, China
  • Hepatocellular Carcinoma With Portal Vein Tumour Thrombus - Terence Kiat Beng Teo, Singapore
  • SIRT In Portal Vein Invasion - Ramon Augusto Hilarion S. Santos-Ocampo, Philippines

MDT ROUND TABLES

MDT Round Table 5 (MDT 5)
Lecture Hall A, 0830hrs – 1000hrs


Renal And Urologic Malignancies

  • Staging Of RCC: TNM Classifications And Its Relevance To Oncologic Interventions - Malinda Abd Majid, Malaysia
  • Urological Management Of RCC: What’s On The Plate? - Xeng Inn Fam, Malaysia
  • Oncological Management Of RCC: New Targeted Drugs & Outcome - Gwo Fuang Ho, Malaysia
  • Percutaneous Ablation Of Small Renal Tumours - Andreas Adam, United Kingdom
  • Long Term Outcomes Of Combination Of Embolisation And Ablation Of T1b Renal Cell Carcinoma - Shuvro Roy Choudhury, India
  • Cryoablation In RCC: How Big Can We Freeze? - Peter Goh, Singapore
  • Ultrasound-Guided Percutaneous Microwave Ablation For Renal Cell Carcinoma At Clinical Staging T1a - Zhi-Gang Cheng, China
  • IRE For Renal Tumours - Gerard S Goh, Australia

MDT Round Table 6 (MDT 6)
Lecture Hall C, 0830hrs – 1000hrs


Colorectal Carcinoma: Chemoresistant Colorectal Liver Metastases

  • DEB TACE In Colorectal Liver Metastases: Review Of Literature - TBC
  • Individualised Treatment For Colorectal Cancer - Muhammad Azrif Ahmad Anuar, Malaysia
  • Hepatic Artery Infusion With FOLFOX ± Bevacizumab For Colorectal Cancer Liver Metastases. A Retrospective Study - Ai-Wei Feng, China
  • Debate:
    1. Surgical Resection Should Be The Mainstay In The Management Of Pauci Metastatic Liver Disease - Boon Koon Yoong, Malaysia
    2. Thermal Ablation Should Be The Mainstay In The Management Of Pauci Metastatic Liver Disease - Hua Xiang, China
  • DEBIRI In CRC Liver Metastases: The Power Of Small Size (LC -Bead M1) - Toshihiro Tanaka, Japan

MDT Round Table 7 (MDT 7)
Lecture Hall A,1100hrs – 1300hrs


Functional Precision Medicine In Lung Cancer Management

  • Endobronchial Ultrasound (EBUS) In Lung Cancer Diagnosis And Staging - Yong Kek Pang, Malaysia
  • Molecular Pathology In Lung Cancer: Why Post Progression Biopsy Is Essential? - Pathmanathan Rajadurai, Malaysia
  • Lung Cancer: The Relative Roles Of SABR And Thermal Ablation - Andreas Adam, United Kingdom
  • Resection In Lung Cancer: Feasibility And Outcome - Mohamad Arif Muhammad Nor, Malaysia
  • Targeted Drugs In Lung Cancer - Matin Mellor, Malaysia
  • Downstaging Of Stage 3 NSCLC For Surgical Resection: Clinical Feasibility And Outcomes - Chong Kin Liam, Malaysia
  • IR In Lung Tumours: What’s In The Horizon? - Jean Palussière, France
  • Tracheobronchial Interventions In Lung Malignancy - Suyash Kulkarni, India

MDT ROUND TABLES

  • Case Capsule:
    1. MDT Management Of Tracheal Adenoid Cystic Carcinoma With Airway Occlusion: Argon Plasma Coagulation Combined With Tracheobronchial Transarterial Chemosaturation - Melisa Seer Yee Lim, Malaysia

MDT Round Table 8 (MDT 8)
Lecture Hall C, 1100hrs – 1200hrs


Hepatocellular Carcinoma 3: Management Of Early HCC

  • Case Capsules In Imaging Of Early HCC - Linda Brown, Thailand
  • Debate:
    1. Surgery Is The Treatment Of Choice In Early HCC - Krishnan Raman, Malaysia
    2. Non-Surgical Option Is The Treatment Of Choice In Early HCC - Matthew Johnson, USA
  • Randomised Trials In Early HCC: Surgery Vs Ablation - Danny Cho, Hong Kong, China
  • Conventional TACE In Early HCC: Literature Review And Data Update - Shiro Miyayama, Japan

SPECIAL SESSIONS

Special Session 10
Lecture Hall F, 0830hrs – 1000hrs


Imaging In Post Cancer Treatment
TBC

Special Session 11
Lecture Hall D, 1100hrs – 1300hrs


General Interventions For Clinical Radiologists

  • Setting Up A Basic IR Service. What Do We Need? - Nik Azuan Nik Ismail, Malaysia
  • Coagulation Parameters Before A Procedure - Ganeshwara Durai Raja Lingam, Malaysia
  • IV Access. Catering For Patients’ Basic Needs - Ridzuan Abdul Rahim, Malaysia
  • Drainages. Ultrasound Or CT Guidance? - Chandran Nadarajan, Malaysia
  • Biopsies. When To Say No - Nur Adura Yaakup, Malaysia
  • FNAC And Biopsy Of Thyroid Nodules. Pearls And Pitfalls - Fadhli Mohamed Sani, Malaysia
  • Complications. Is It Avoidable? - Norshazriman Sulaiman, Malaysia
  • Bone Biopsies. Different Tools For Different Lesions - Muhammad Fadli Embong, Malaysia
  • Special Session 12
    Lecture Hall C, 1400hrs – 1600hrs


    Film Panel Session
    TBC

Morbidity & Mortality

Morbidity & Mortality 2 (M&M 2)
Lecture Hall D, 1400hrs – 1600hrs


My Worse Nightmare

  • Case Presentations With Learning Objectives
    1. Bad Outcome
    2. Good Outcome

Extreme IO Case Challenges

Extreme IO Case Challenge 6
Lecture Hall E, 1100hrs – 1300hrs

Case Presentations & Discussion

Extreme IO Case Challenge 7
Lecture Hall E, 1400hrs – 1600hrs

Case Presentations & Discussion

Breakfast Symposiums

Industrial Breakfast Symposium By Guerbet
Lecture Hall A, 0730hrs - 0830hrs


Conventional TACE For Hepatocellular Carcinoma

  • Case Stratification & Pre-Procedural Assessment / Preparation - Simon Yu, Hong Kong, China
  • Angiographic Analysis In HCC - Jin-Wook Chung, South Korea
  • Water In Oil Vs Oil In Water: The Bench Top Analysis And Its Clinical Implications - Thierry De Baere, France
  • How Do I Do Superselective cTACE, Its End Point And Why cTACE Fails - Shiro Miyayama, Japan

APCIO MEETS TSVIR

Lecture Hall C, 1200hrs – 1300hrs

APCIO Meets TSVIR

  • How To Perform cTACE As Curative Aim For A Small HCC? - Kittipitch Bannangkoon, Thailand
  • IR Role In Colorectal Metastasis In Thailand - Nutcha Pinjaroen, Thailand
  • Fellowship IR Training Program In Thailand: Domestic And International - Somrach Thamtorawat, Thailand

Lunch Symposiums

Lunch Symposium By Guerbet
Lecture Hall A, 1300hrs - 1400hrs


The Power Of Lipiodol

  • Standardisation Of cTACE Using Vectorio - Thierry De Baere, France
  • SeQure® And DraKon™ Microcatheters: The Power Of Superselectivity And Antireflux - Jean-Pierre Pelage, France
  • Back To Liquid : Lipiodol And Alcohol In Giant HCC, A Stepwise Approach - Alex Tang, Malaysia

Tea Symposiums

Tea Symposium By Siemens
Lecture Hall D, 1000hrs - 1100hrs

  • Optimising Workflow In Transradial Interventions And Cone Beam CT For Cementoplasty - Chow Wei Too, Singapore

Booth Symposiums

Booth Tea Symposium By Boston Scientific
1000hrs - 1100hrs

  • Interlock Detachable Embolisation Coil In Interventional Oncology - Sundeep Jaywantraj Punamiya, Singapore

Booth Tea Symposium By Canon Medical
1000hrs - 1100hrs

  • AI In Radiology - Where Are We Now Today? - Ken Loo
  • Canon Healthcare IT, Oncology Imaging Solution For Better Patient Care - Nicolas Pieropan

Nurse / Radiographer Session

Nurse / Radiographer Session
Lecture Hall E, 0830hrs – 1000hrs

TBC